Oneg Hakarmel

Company Overview

Snapshot

Founded in January 2002 by Prof. Noam Gavriely, Oneg Hakarmel operates with 11–50 employees. The company focuses on developing medical devices for various surgical and emergency applications. In November 2018, Oneg Hakarmel launched HemaShock, an emergency auto-transfusion tourniquet designed to improve survival rates in cases of severe shock or cardiac arrest.

Business overview

Oneg Hakarmel manufactures and sells products for orthopedic surgery, vascular surgery, and emergency medicine. Its core technology involves patent-protected, single-use devices that efficiently displace blood from limbs and prevent its re-entry, creating a bloodless surgical field. The company's HemaClear line of sterile surgical products is widely used for this purpose, while the EED product line is designed for emergency medicine to auto-transfuse a patient's own blood during severe shock or cardiopulmonary resuscitation. Oneg Hakarmel's products are FDA listed and CE marked, serving the healthcare and life sciences sectors, particularly providers.

Strategic signal

In January 2019, Oneg Hakarmel's HemaShock device garnered significant attention, highlighted by articles in FMIBlog and The Jerusalem Post. This device, launched in November 2018, is an emergency auto-transfusion tourniquet designed to rapidly move blood from limbs into central circulation during severe shock or cardiac arrest. This indicates a strategic focus on critical care solutions and positions the company as an innovator in emergency medical devices with the potential to significantly impact patient outcomes.

Company Intelligence Q&A

What is Oneg Hakarmel's primary focus?

Oneg Hakarmel specializes in manufacturing and selling products for orthopedic surgery, vascular surgery, and emergency medicine, with a focus on devices that manage blood flow during medical procedures.

When was the HemaShock product launched?

Oneg Hakarmel launched HemaShock, an emergency auto-transfusion tourniquet, in November 2018.

What is the purpose of the HemaClear product line?

The HemaClear line of sterile surgical products is designed to create a bloodless surgical field, which is widely used in various surgical procedures.

What is the EED product line used for?

The EED system, developed by Oneg Hakarmel, is used in emergency medicine to auto-transfuse a patient's own blood from their limbs into central circulation during severe shock or cardiopulmonary resuscitation.

Has Oneg Hakarmel's technology received regulatory approvals?

Yes, Oneg Hakarmel's HemaClear product is FDA listed and CE marked, indicating compliance with regulatory standards in the United States and Europe.